| 摘要: |
| ［摘要］ 目的 探讨孟鲁司特钠联合特布他林治疗儿童咳嗽变异性哮喘伴肺炎支原体感染的可行性。方法 将98例儿童咳嗽变异性哮喘伴肺炎支原体感染的患儿随机分为观察组和对照组各49例。对照组给予特布他林治疗，观察组在对照组的基础上给予孟鲁司特钠治疗，疗程12周，比较两组临床疗效以及临床不适症状等。结果 观察组显效35例，有效11例，无效3例，对照组显效25例，有效13例，无效11例。观察组疗效优于对照组（P<0.01）；且临床症状改善时间短于对照组（P<0.01）。结论 儿童咳嗽变异性哮喘伴肺炎支原体感染患儿采用孟鲁司特钠联合特布他林治疗，能有效改善临床症状及体征，疗效确切，安全性高，不良反应少，具有一定可行性。 |
| 关键词: 咳嗽变异性哮喘 肺炎支原体感染 孟鲁司特钠 特布他林 |
| DOI：10.3969/j.issn.1674-3806.2017.02.17 |
| 分类号:R 56 |
| 基金项目: |
|
| Montelukast combined with terbutaline for the treatment of children with cough variant asthma complicated with mycoplasma pneumoniae infection |
|
LI Ning
|
|
The People′s Hospital of Liuyang, Hunan 410300, China
|
| Abstract: |
| ［Abstract］ Objective To explore the feasibility of montelukast combined with terbutaline for the treatment of cough variant asthma complicated with mycoplasma pneumoniae infection in children.Methods Ninety eight children with cough variant asthma complicated with mycoplasma pneumoniae infection were randomly divided into two groups, with 49 cases in each group. The patients in the control group were treated with terbutaline therapy, and the patients in the observation group received montelukast treatment on the basis of that applied on the patients in the control group. The clinical efficacy and clinical symptoms of the patients were compared between the two groups.Results In the observation group, 35 cases were markedly effective, 11 effective and 3 ineffective, while in the control group, 25 cases were markedly effective, 13 effective and 11 ineffective. The treatment efficacy of the observation group was better than that of the control group(P<0.05).Conclusion Montelukast combined with terbutaline can effectively improve the clinical symptoms and signs, reduce adverse reactions for treatment of children with cough variant asthma complicated with mycoplasma pneumoniae infection. |
| Key words: Cough variant asthma Mycoplasma pneumoniae infection Montelukast Terbutaline |
